Lilly Sues 4 Compounders Over Copies of Weight-Loss Drugs

Share!

Insurance Journal - Apr 24, 2025

Eli Lilly said Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, after a U.S. judge last month blocked pharmacies from making copies of its weight-loss and diabetes medicines. Compounders were, until recently, allowed to produce copies …...

Read Full Article

Recommended Articles

PG&E Misses 1Q Profit Estimates on Higher Expenses, LA Wildfire Worries Linger

Posted: Apr 24, 2025

PG&E Corp. missed first-quarter profit estimates on Thursday, as the power company was hurt by h...

People Moves: Ryan Specialty Appoints Kelleher President of SUITELIFE Underwriting Managers

Posted: Apr 24, 2025

Ryan Specialty, headquartered in Chicago, Illinois, appointed Chris Kelleher president of SUITELIFE...

Wife of Former US Sen. Bob Menendez Convicted in Bribery Scheme

Posted: Apr 24, 2025

Nadine Menendez, the wife of former U.S. Sen. Bob Menendez, was convicted of teaming up with her hus...